Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Filippa Stenberg joins Mölnlycke Board of Directors
Gothenburg, Sweden, 4 June 2025.
Mölnlycke is pleased to announce the election of Filippa Stenberg as a deputy board member to its Board of Directors, as of 22 May 2025. Filippa brings over a decade of experience in active ownership with a focus on healthcare investments. She currently serves as a Managing Director of Patricia Industries, part of Investor AB, where she has been instrumental in driving value creation in several globally leading companies.
“We are delighted to welcome Filippa to the Mölnlycke Board,” said Karl-Henrik Sundström, Chairman of the Board. “Her energy, expertise and experience, as well as her strategic vision, will be a tremendous asset to Mölnlycke as we continue to advance our growth journey.”
“I am honoured to join the Mölnlycke Board at such a pivotal time,” added Filippa. “The company has been experiencing strong growth in a healthcare landscape that is continuously evolving. I very much look forward to working with the team to help fulfil the company’s purpose to revolutionise care for people and planet.”
Filippa Stenberg was born in 1985 and is a Swedish citizen. She has been a board member of Swedish Orphan Biovitrum AB since 2021 and recently joined the board of Affibody Medical AB. She has worked as an investment professional at Investor AB since 2012, Chief Strategy Officer at Atlas Antibodies and analyst at Swedbank. She holds an MSc in Business and Economics from the Stockholm School of Economics.
For more information, please contact:
Latest news
Read all news-
Mölnlycke recognised with EUPD’s ‘ESG Transparency Award
We are delighted to announce that Mölnlycke was recognised with ‘ESG Transparency Award' by EUPD Research. Mölnlycke achieved the highest excellence level with the total score of 95,5%.
-
Shaping wound care policy across Europe
We are proud to play our part in shaping the future of wound care in Europe. Mölnlycke has been elected one of the organisations leading the Wound Care Sector Working Group at MedTech Europe, the industry association representing medical technology across the continent.
-
2025 Future Summit by Mölnlycke Health Care
Smarter incision care and partnerships are key to enhanced clinical practise and improved patient outcomes.
-
Mölnlycke donates patent to spark innovation in sustainable healthcare
Gothenburg, Sweden. 12 November 2025. Mölnlycke Health Care, a global leader in MedTech, is the first company to donate a patent to SKF’s groundbreaking digital platform, The Patent Bay – taking bold action to harness collaboration and accelerate innovation in sustainable healthcare.
-
Mölnlycke establishes first wound care manufacturing site in China
Changshu, China, and Gothenburg, Sweden. 5 November 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke’s growth journey and the beginning of localised manufacturing in one of the world’s fastest-growing MedTech markets.
-
Mölnlycke Health Care’s global headquarters ranked number one workplace in Sweden and top 20 globally in Leesman workplace experience survey
Gothenburg, Sweden, 15 October 2025 Mölnlycke® Health Care is proud to announce that its global headquarters have placed number one in Sweden, and top 20 globally, in the prestigious Leesman® Index, a benchmark survey measuring workplace experience across thousands of organisations worldwide.
-
Mölnlycke Health Care breaks ground on $135 million expansion of Wound Care manufacturing facility in Brunswick, Maine
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.
-
Media room: Mölnlycke Brunswick, Maine site expansion
-
High burnout among operating room staff poses significant risk to patient safety—new review reveals
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.